Antimicrobial Agents and Chemotherapy (AAC) announced that Cesar Arias, MD, PhD, will be its new editor in chief starting July 2020. Dr. Arias is part of the ARLG Laboratory Consortium team. He has received international recognition for his work conducting basic, translational and clinical research on antibiotic resistance.
The AAC is an American Society for Microbiology (ASM) journal that covers interdisciplinary studies that increase knowledge of underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy. Dr. Arias has served as an AAC editorial board member since 2009 and an editor since 2014.